Is Travere Therapeutics Inc halal to invest in?

As of July 2026, Travere Therapeutics Inc TVTX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Travere Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Travere Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Travere Therapeutics Inc?

Muslim investors may consider investing in Travere Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Travere Therapeutics Inc classified as HALAL?

Musaffa determines the Shariah status of Travere Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Travere Therapeutics Inc updated?

The Shariah compliance status of Travere Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Travere Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Travere Therapeutics Inc?

You can check the latest Shariah compliance status of Travere Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TVTX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Travere Therapeutics Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Travere Therapeutics Inc. Stock Analysis TVTX

United States Health Care Mid Cap Report: Q1, 2026

Travere Therapeutics, Inc. is a biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 497 full-time employees. The company went IPO on 2003-07-23. The firm is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. FILSPARI is an oral, once-daily, non-immunosuppressive medication that directly targets glomerular injury in the kidney. Sparsentan is also in late-stage development for focal segmental glomerulosclerosis (FSGS). The Company’s Pegtibatinase is a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria (HCU), which is a rare metabolic disorder. Its commercial products, Thiola and Thiola EC, are for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones.

Key Statistics of Travere Therapeutics Inc (TVTX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$55.29$56.18

Today's Open

$55.29

Volume

752.85K

P/E Ratio (TTM)

52 Week Range

$15.03$60.10

Market Cap

5.43B

Avg. Volume

1.97M

Dividend Yield

Financial Metrics & Statements of Travere Therapeutics Inc (TVTX)

Super Investors Invested in Travere Therapeutics Inc (TVTX)

FAQ's for Travere Therapeutics Inc (TVTX)

As of July 2026, Travere Therapeutics Inc TVTX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Travere Therapeutics Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Travere Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Travere Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Travere Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Travere Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.